A new saliva test, Endotest, has been approved in the United Kingdom for use in clinicians' offices, offering a potential breakthrough in the diagnosis of endometriosis. The test analyzes saliva samples for specific microRNAs that indicate the likely presence of the condition, which affects approximately 190 million women globally.
Historically, women may wait up to 11 years from the onset of symptoms to receive an endometriosis diagnosis, according to Yale Medicine. This lengthy delay can lead to delayed treatment and prolonged suffering. The Endotest, approved by the UK's National Institute for Health and Care Excellence (NICE) for a three-year period, aims to significantly shorten this diagnostic timeline.
Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, leading to symptoms such as chronic pain, fatigue, and infertility. The condition is often challenging to diagnose because its symptoms can mimic other ailments, and existing diagnostic tools have limitations. "There is no good blood test or imaging modality that can detect endometriosis," noted Dr. Sheeva Talebian, a reproductive endocrinologist. Pelvic MRIs, for example, may not detect the disease in its early stages.
The complexity of diagnosis is compounded by the fact that the severity of symptoms does not always correlate with the stage of the disease. If left untreated, endometriosis can lead to severe complications, including a "frozen pelvis," where inflammation and scar tissue cause organs like the ovaries, bladder, and bowel to fuse. It can also significantly impair fertility by reducing ovarian reserve and blocking fallopian tubes.
"These tests are a game-changer because they give us answers much earlier, without the need for invasive surgery," stated Dr. Gail Busby, a consultant gynecologist at Manchester University NHS Foundation Trust. Early diagnosis facilitated by tests like Endotest can expedite treatment and also help alleviate pressure on healthcare systems by freeing up appointments and surgical slots for other patients awaiting care.